The North American preclinical in vivo imaging market is referred to a powerhouse of biomedical research, defined by the non-invasive visualization and monitoring of biological processes within living animal models to bridge the gap between laboratory discovery and clinical application. This sector is currently defined by high-speed innovations, particularly the integration of artificial intelligence (AI) for automated image quantification and the rise of multimodal systems (like PET/MRI and SPECT/CT) that offer simultaneous functional and anatomical data.